Immunogeneicity of Recombinant TherapeuticInterferon Alpha by Hafiza Rida Farooq Chudhary in Research and Reviews on Healthcare: Open Access Journal (RRHOAJ)- Lupine Publishers
Therapeutic recombinant interferons and cytokines are being used to
treat different diseases but these proteins can start
immunogenic reactions. These reactions neutralize the effect of
therapeutic proteins and make them useless. There are many factors
responsible for causing and effecting immunogenicity including dosage,
route of administration, genetic status, and polymorphism
and Allergic responses. The body’s first immune response against
recombinant therapeutic cytokines is mediated by innate system,
subsequently activating the adaptive immune system. The key factors in
immunogenicity are the glycosylation and aggregated structure
of therapeutic protein that distinguishes the protein/cytokine from
self-proteins. There are many ways to reduce immunogenicity like to
decrease the number of epitopes for T-cells or by screening the history
of allergies. IFNs are basically proteins in nature many of which
are related both in 3D structure and amino acid sequences. Recombinant Interferons are widely used these days against viral infections
and cancers. In this review the antiproliferative activity and the
effects of various recombinant human interferons on the cytotoxic and
cytostatic activity of natural killer cells and monocytes are discussed
in detail. Many diseases are being treated with drugs having protein nature. These
exogenous proteins having therapeutic role are used as a replacement
therapy for self-proteins. These Protein therapeutics are checked and
analyzed to maintain biosafety measures and toxicity, viral and
bacterial contaminations are removed. Beyond checking these measure
there is immune response to a protein drug that is called
"immunogenicity" can neutralize the effect of therapeutic cytokine
(Barandun and others [1]; Dasgupta and others [2]). The concept was that
'self' derived protein therapeutics like recombinant human cytokines IFNβi-3 IFNα4,5 GM-CSF6 and human anti-TNFa7,8 antibodies will not cause
immunogenicity.
For more information click on below link
For more Lupine Open access publishers go through the link
For click Journal of Research and Review below link
No comments:
Post a Comment